Skip to content

Sequencing Combined with Plasma Proteomics for Dissecting the Immuno: Molecular Signatures of Sepsis Acute Kidney Injury

Single-Cell Sequencing Combined with Plasma Proteomics for Dissecting the Immuno: Molecular Signatures of Sepsis Acute Kidney Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119324
Enrollment
Unknown
Registered
2026-02-25
Start date
2026-02-25
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis-associated acute kidney injury

Interventions

sepsis without acute kidney injury group:N/A
sepsis with acute kidney injury group:N/A

Sponsors

Fuzhou University Affiliated Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meets the internationally recognized diagnostic criteria for sepsis [Sepsis-3 criteria, i.e., infection accompanied by a Sequential Organ Failure Assessment (SOFA) score>=2]; (2) Age 18-80 years; (3) Patients who have not died or been discharged voluntarily within 48 hours of ICU admission; (4) Patient/family has signed the informed consent form; (5) Able to cooperate to complete a one-year follow-up observation;

Exclusion criteria

Exclusion criteria: 1.Aged under 18 years or over 80 years; 2.Complicated with acute kidney injury (AKI), severe liver disease, chronic kidney disease, chronic renal insufficiency, or end-stage renal disease prior to ICU admission; 3.Patients with malignant tumors, rheumatic immune system diseases, hematologic diseases (e.g., leukemia, aplastic anemia, etc.) that may affect the quantity and function of peripheral blood cells, autoimmune diseases, organ transplantation, or splenectomy; 4.Pregnant patients; 5.Patients who have received immunosuppressant therapy or hormone therapy recently (within 3 months); 6.Length of ICU stay less than 48 hours; 7.Known allergy or contraindication to study-related tests; 8.Poor compliance and inability to complete follow-up observations; 9.Other conditions deemed ineligible for enrollment by the investigators;

Design outcomes

Primary

MeasureTime frame
Natural Killer Cell;Cytokines: PCT, C-reactive protein, IL-6, NT-proBNP, troponin I;T cell subsets(CD3?CD4?CD8);Complete Blood Count;Comprehensive Biochemical Profile;serum Cystatin C;Arterial Blood Gas?Blood Lactic Acid;

Secondary

MeasureTime frame
Onset time of sepsis-associated acute kidney injury;time to recovery of serum creatinine to normal levels;Hospital LOS (Length of Stay),ICU LOS;ICU mortality, mortality at 60?90 and 180 days;Proportion of sepsis-associated AKI progressing to CKD;

Countries

China

Contacts

Public ContactHangwei Feng

Fuzhou University Affiliated Provincial Hospital

563492784@qq.com+86 591 8861 8701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026